Поликлиническая педиатрия / Клинические рекомендации (разных лет) / ПНЕВМОНИИ

Review. J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):323-334.

[48]Andronikou S, Lambert E, Halton J, Hilder L, Crumley I, Lyttle MD, Kosack C. Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents. Pediatr Radiol. 2017 Oct;47(11):1405-1411.

[49]Le Roux DM, Zar HJ. Community-acquired pneumonia in children - a changing spectrum of disease. Pediatr Radiol. 2017 Oct;47(11):1392-1398. doi: 10.1007/s00247-017-3827-8 37, 38.

[50]Levinsky Y, Mimouni FB, Fisher D, Ehrlichman M (2013) Chest radiography of acute paediatric lower respiratory infections: experience versus interobserver variation. Acta Paediatr 102:e310–e314.

[51]Nascimento-Carvalho CM, Araújo-Neto CA, Ruuskanen O. Association between bacterial infection and radiologically confirmed pneumonia among children. Pediatr Infect Dis J. 2015 May;34(5):490-3..

[52]Novack V, Avnon LS, Smolyakov A, et al. Disagreement in the interpretation of chest radiographs among specialists and clinical outcomes of patients hospitalized with suspected pneumonia. EurJ Intern Med 2006; 17:43–7..

[53]Johnson J, Kline JA. Intraobserver and interobserver agreement of the interpretation of pediatric chest radiographs. Emerg Radiol. 2010 Jul;17(4):285-90..

[54]Weigl J. Community acquired pneumonia in Germany. 21th Ann.Meeting of ESPID, Taormina, Sicily, April 9-12, 2003, abstr.47:p.24.

[55]Orso D, Ban A, Guglielmo N. Lung ultrasound in diagnosing pneumonia in childhood: a systematic review and meta-analysis. J Ultrasound. 2018 Sep;21(3):183-195.

[56]Kumar RM, Kabra SK, Singh M. Efficacy and acceptability of different modes of oxygen administration in children: implications for a community hospital. J Trop Pediatr 1997;43:47e9.

[57]Lodha R, Kabra SK, Pandey RM. Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev. 2013 Jun 4;2013(6):CD004874.

[58]Infants and Children: Acute Management of Community Acquired Pneumonia – NSW Health – Guideline – March 2018 .

[59]Klein JO. Bacterial pneumonias. In: Cherry J, Kaplan S, DemmlerHarrison G eds. Feigin &

Cherry’s textbook of pediatric infectious diseases, 6th ed. Vol 1. Philadelphia, PA: Saunders/Elsevier, 2009; 302–14.

[60]McCracken GH Jr. Etiology and treatment of pneumonia. Pediatr Infect Dis J 2000; 19:373– 7..

[61]Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatric Infectious Diseases Journal. 1996; 15:255–9.38..

[62]Hazir T, Qazi SA, Bin Nisar Y, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2–59 months: a multi-centre, double blind, randomised controlled trial in Pakistan., «2007; 92:291–7».

[63]Sader HS, Jacobs MR, Fritsche TR. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Diagn Microbiol Infect Dis 2007; 57:5S–12S.

[64]Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolidesensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. J Infect Chemother 2009; 15:380–3..

[65]Lee H, Yun KW, Lee HJ, Choi EH. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children. Expert Rev Anti Infect Ther. 2018 Jan;16(1):23-34..

[66]Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database of Systematic Reviews. 2008; CD:005976.

[67]Pernica J. M., Harman S., Kam A.J. et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia. The SAFER randomized clinical trial. JAMA Pediatr. Published online March 8, 2021.

[68]Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis imroves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011; 30:289–94.

[69]Bradley JS, Ching DK, Hart CL. Invasive bacterial disease in childhood: efficacy of oral antibiotic therapy following short course parenteral therapy in non-central nervous system infections. Pediatr Infect Dis J 1987; 6:821–5.

[70]Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014; 4:CD008965.

[71]Таточенко В. К. (ред). Острые пневмонии у детей. Чебоксары, 1994, 323 с..

[72]Таточенко В.К. Болезни органов дыхания у детей. 7 изд.. М. Боргес 2019: 300 стр..

[73]Kim HS, Sol IS, Li D. Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials. BMC Pulm Med. 2019 Dec 18;19(1):251.

[74]Sun LL, Ye C, Zhou YL. Meta-analysis of the Clinical Efficacy and Safety of Highand Low-dose Methylprednisolone in the Treatment of Children With Severe Mycoplasma

Pneumoniae Pneumonia. Pediatr Infect Dis J. 2020 Mar;39(3):177-183.

[75]Das RR, Singh M, Naik SS. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia. Cochrane Database Syst Rev. 2018 Jul 19;7(7):CD011597.

[76]Balk DS, Lee C, Schafer J, Welwarth J, Hardin J, Novack V, Yarza S, Hoffmann B. Lung ultrasound compared to chest X-ray for diagnosis of pediatric pneumonia: A meta-analysis. Pediatr Pulmonol. 2018 Aug;53(8):1130-1139..

[77]Carter E, Waldhausen J, Zhang W, et al. Management of children with empyema: pleural drainage is not always necessary. Pediatr Pulmonol 2010; 45:475–80..

[78]The Green Book. Immunization against infections disease. 2013. Part 2, ch. 16. p. 127–143.

[79]Jones LL, Hashim A, McKeever T. Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis. Respir Res. 2011;12(1):5.

[80]Watererl G., Bennett L. Improving Outcomes From Community-acquired Pneumonia. Curr Opin Pulm Med. 2015;21(3):219-225.

[81]Gattarello S, Borgatta B, Sole-Violan J, et al., Investigators CIs. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000–2013). Chest 2014; 146:22–31.

[82]Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164:637–644.

[83]Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev 2012; 8:CD001831.

[84]Chalumeau M., Duijvestijn Y.C. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic bronchopulmonary disease. Cochrane Database Syst Rev. 2013 May 31;5:CD003124.

[85]Манеров Ф.К., Паули Б.А., Чернов О.М. с соавт. Клинические варианты пневмококковых пневмоний и характеристика их течения и исходов. Педиатрия 1990;№3:22—28.

[86]Dean P, Florin TA. Factors Associated With Pneumonia Severity in Children: A Systematic Review. J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):323-334.

[87]Andronikou S, Lambert E, Halton J, Hilder L, Crumley I, Lyttle MD, Kosack C. Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents. Pediatr Radiol. 2017 Oct;47(11):1405-1411.

[88]Orso D, Ban A, Guglielmo N. Lung ultrasound in diagnosing pneumonia in childhood: a systematic review and meta-analysis. J Ultrasound. 2018 Sep;21(3):183-195.